Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies

Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies

Xinming Han,1 Yan Han,2 Yongsheng Zheng,1 Qiang Sun,1 Tao Ma,1 Li Dai,1 Junyi Zhang,1 Lianji Xu1 1Plastic Surgery Department, Beijing Tongren Hospital, Capital Medical University, Beijing, 2Plastic and Reconstructive Surgery Department, Chinese PLA General Hospital, Beijing, China Background: Phos...

Full description

Bibliographic Details
Main Authors: Han X, Han Y, Zheng Y, Sun Q, Ma T, Dai L, Zhang J, Xu L
Format: Article
Language:English
Published: Dove Medical Press 2018-02-01
Series:OncoTargets and Therapy
Subjects:
Phosphodiesterase type 5 inhibitors
Melanoma
Meta-analysis
Sildenafil
Online Access:https://www.dovepress.com/use-of-phosphodiesterase-type-5-inhibitors-and-risk-of-melanoma-a-meta-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/use-of-phosphodiesterase-type-5-inhibitors-and-risk-of-melanoma-a-meta-peer-reviewed-article-OTT

Similar Items